prednisone

prednisone is a synthetic glucocorticoid medication primarily used to suppress the immune system and reduce inflammation. It is a cornerstone in the management of numerous conditions, ranging from autoimmune disorders like rheumatoid arthritis and lupus to severe asthma and certain malignancies. The drug is a prodrug, converted in the liver to its active form, prednisolone, and is typically administered orally. Its development in the 1950s by the Schering Corporation and Merck & Co. marked a significant advancement in steroid therapy, though its potent effects are balanced by a well-documented profile of potential adverse reactions.

Medical uses

It is prescribed for a wide spectrum of inflammatory and immune-mediated conditions. Common uses include managing exacerbations of asthma and chronic obstructive pulmonary disease, treating acute flares of rheumatoid arthritis and systemic lupus erythematosus, and controlling symptoms of inflammatory bowel disease such as Crohn's disease. In oncology, it forms part of chemotherapeutic regimens for lymphomas and leukemias, often in combination with agents like vincristine. It is also used in suppressing organ transplant rejection and treating certain dermatological conditions like pemphigus vulgaris. The American College of Rheumatology and the Global Initiative for Asthma provide guidelines for its appropriate use in their respective fields.

Adverse effects

Prolonged use is associated with numerous adverse effects, many related to its glucocorticoid activity. These include Cushing's syndrome, characterized by moon face and central obesity, osteoporosis, increased risk of infection due to immunosuppression, hyperglycemia which can exacerbate or induce diabetes mellitus, hypertension, cataract formation, and peptic ulcer disease. Psychiatric effects such as insomnia, mood swings, and psychosis are also possible. The risk and severity are dose and duration-dependent, leading to clinical strategies like alternate-day dosing and the use of steroid-sparing agents recommended by bodies like the Food and Drug Administration.

Pharmacology

As a prodrug, it is metabolized in the liver by the enzyme 11β-hydroxysteroid dehydrogenase to its active form, prednisolone. This active metabolite binds to the glucocorticoid receptor within cell nuclei, modulating the transcription of numerous genes. This leads to the inhibition of pro-inflammatory proteins like cyclooxygenase-2 and various cytokines, while promoting the synthesis of anti-inflammatory proteins. Its actions result in profound immunosuppression, anti-inflammatory effects, and influence on carbohydrate, protein, and lipid metabolism. The plasma protein binding is primarily to albumin and its elimination half-life is approximately 3 to 4 hours.

History

Its synthesis was first reported in 1955 by the Schering Corporation and independently by Merck & Co., following the groundbreaking discovery of the anti-inflammatory properties of cortisone at the Mayo Clinic by Philip Showalter Hench. The goal was to create a synthetic corticosteroid with greater anti-inflammatory potency and reduced mineralocorticoid activity compared to hydrocortisone. Its introduction represented a major therapeutic advance, allowing for more effective management of rheumatoid arthritis and other conditions. Subsequent research, including work by scientists like Tadeusz Reichstein, who won the Nobel Prize in Physiology or Medicine for work on adrenal hormones, further elucidated the role of steroids in medicine.

Society and culture

It is available as a generic medication and is on the World Health Organization's List of Essential Medicines. Brand names have included Deltasone and Rayos. Its use and potential for side effects have been depicted in various media, contributing to public awareness of the challenges of chronic illness management. The drug's impact is also felt in sports, where its systemic use is generally prohibited by the World Anti-Doping Agency without a valid therapeutic use exemption. Cost and access issues, particularly for long-term therapy, are subjects of discussion within healthcare systems like the National Health Service and among insurers in the United States.

Category:Drugs